Markets:

Overview

News

Currencies

International

Treasuries

Vanguard Health Care ETF (NY:VHT)

280.41 -1.58 (-0.56%)

Official Closing Price Updated: 4:10 PM EDT, Jun 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Health Care ETF

< Previous 1 2 3 4 5 Next >

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy? ↗

Today 6:41 EDT

Broader diversification or higher yield? Explore how these two healthcare ETFs stack up for different investor goals.

Via The Motley Fool

Topics ETFs

Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Year, According to Wall Street ↗

June 03, 2026

Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year.

Via The Motley Fool

Topics ETFs Intellectual Property Stocks

Vanguard (VHT) Vs. Simplify (PINK): Which Healthcare ETF Is the Better Buy for Investors? ↗

June 02, 2026

Explore how two healthcare ETFs stack up in cost, yield, and strategy, with one fund emphasizing innovation and charitable impact.

Via The Motley Fool

Topics ETFs

U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ ↗

June 01, 2026

The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S....

Via The Motley Fool

Topics ETFs Intellectual Property

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost ↗

May 28, 2026

Expense ratios, yield, and sector breadth set these healthcare ETFs apart—see how their risk profiles and portfolio strategies compare.

Via The Motley Fool

Topics ETFs

3 ETFs That Historically Perform Well in the Final Weeks of May ↗

May 22, 2026

May's reputation isn't as bad as some investors think, and this mix of ETFs can get the job done as summer nears.

Via The Motley Fool

Topics ETFs

Medicine's Not Going Anywhere: 3 of the Most Resilient Healthcare ETFs ↗

May 21, 2026

It's tough to think of an industry with more staying power than healthcare.

Via The Motley Fool

Topics ETFs Retirement

3 Vanguard ETFs to Buy to Protect Your Portfolio From a Potential Stock Market Crash ↗

May 01, 2026

There are enough economic signals to think that a bear market could be a real risk, so it's time to think about ways to protect yourself.

Via The Motley Fool

Topics ETFs Economy

Should You Really Buy Stocks With the S&P 500 Near Its Record High? Historical Data Gives a Clear Answer. ↗

April 22, 2026

Avoiding the stock market at all-time highs has historically been a mistake.

Via The Motley Fool

Topics Bonds Economy Stocks

1 No-Brainer Healthcare Vanguard ETF to Buy Right Now for Less Than $1,000 ↗

April 13, 2026

Healthcare stocks have been laggards for a while now. The current economic slowdown and structural tailwinds make it much more attractive now.

Via The Motley Fool

Topics Artificial Intelligence ETFs Economy

3 ETFs to Own if the U.S. Economy Slows in 2026 ↗

March 30, 2026

The U.S. economy is showing signs of slowing and recession risk is rising. Here's how to prepare your portfolio.

Via The Motley Fool

Topics Artificial Intelligence Bonds ETFs

Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF ↗

March 24, 2026

After nearly tripling between 2023 and the end of 2025, Lilly is undergoing a steep sell-off in 2026.

Via The Motley Fool

Topics ETFs

Why Did CRMD Stock Tumble Over 11% Today? ↗

March 05, 2026

The company reported mixed Q4 results with a revenue of $128.6 million and earnings per share of $0.16.

Via Stocktwits

Topics Artificial Intelligence

HELP Stock Tanks 22% Despite Strong Phase 2 Results For Anxiety Treatment: Retail Buys The Dip Ignoring Market’s Pessimism ↗

March 05, 2026

In the study, participants receiving a 20-milligram dose of HLP004 alongside standard-of-care treatment experienced an average drop of roughly 10.4 points on the Hamilton Anxiety Rating Scale after six...

Via Stocktwits

TLRY Stock Slumps 4%: What’s Driving The Selloff? ↗

March 02, 2026

Tilray said that it has acquired the BrewDog brand and related intellectual property, UK brewing operations and eleven strategic brewpubs in the United Kingdom and Ireland.

Via Stocktwits

Topics Cannabis Intellectual Property

Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue ↗

February 26, 2026

The company generated $147 million in revenue during Q4, a 67% year-on-year (YoY) increase. Earnings per share (EPS) for the quarter were $0.11.

Via Stocktwits

Topics Artificial Intelligence

PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 ↗

February 26, 2026

Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’.

Via Stocktwits

Topics Artificial Intelligence

XWEL Stock Soars 300%, Hits 200-DMA For First Time In Nearly Four Months – What Triggered The Rally? ↗

February 25, 2026

The company signed a securities purchase agreement with American Ventures on Tuesday as part of a private placement worth up to $31.3 million.

Via Stocktwits

Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low? ↗

February 25, 2026

CASI stated the Nasdaq determined that the company had failed to satisfy the continued listing conditions to remain listed on the Nasdaq Stock Market.

Via Stocktwits

Why Did IXHL Stock Tank Over 32% Today? ↗

February 25, 2026

The company’s board approved a 1-for-30 reverse stock split, effective on February 26.

Via Stocktwits

EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious ↗

February 25, 2026

KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’, citing a lack of visibility in near-term EBITDA recovery.

Via Stocktwits

Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? ↗

February 24, 2026

The FDA has granted Breakthrough Therapy Designation to Larimar’s frataxin protein replacement therapy, nomlabofusp.

Via Stocktwits

Why Did IOVA Stock Gain Pre-Market Today? ↗

February 24, 2026

The company announced encouraging early results from a pilot study evaluating its tumor-infiltrating lymphocyte therapy, lifileucel and reported strong fourth-quarter earnings.

Via Stocktwits

Why Did PVLA Stock Surge 45% In Pre-Market Today? ↗

February 24, 2026

The biotech company reported statistically significant Phase 3 data for QTORIN gel.

Via Stocktwits

Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone ↗

February 20, 2026

Baird analyst Catherine Ramsey Schulte slashed the price target on Grail to $82 from $113 while reiterating an ‘Outperform’ rating.

Via Stocktwits

MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event ↗

February 17, 2026

Some Stocktwits users voiced optimism for the inflammation-drug maker getting acquired by pharma giant Merck.

Via Stocktwits

Topics Intellectual Property

IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’ ↗

February 17, 2026

The Saudi Food and Drug Authority encouraged the company to submit a regulatory filing for its recombinant Bacillus Calmette-Guérin, which the company expects to submit within weeks.

Via Stocktwits

Why Did INTS Stock Plummet 30% Pre-Market Today? ↗

February 13, 2026

Intensity Therapeutics announced a 1-for-25 reverse stock split, consolidating every 25 existing shares into a single new share.

Via Stocktwits

NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results ↗

February 10, 2026

Nektar announced positive results from the 36-week blinded maintenance period of the 52-week REZOLVE-AD study of its experimental drug, rezpegaldesleukin.

Via Stocktwits

HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗

February 09, 2026

The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration.

Via Stocktwits

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.